Assessment of expression levels of leptin and leptin receptor as potential biomarkers for risk of prostate cancer development and aggressiveness.
Hala Fawzy Mohamed KamelAnmar M NassirAbeer A Al RefaiPublished in: Cancer medicine (2020)
Leptin and its receptors are suggested to be potential biomarkers for PCa; leptin receptor mRNA might predict risk and aggressiveness of PCa.